Mobile Menu
Deals & Transactions

Conyers advises New WuXi Life Science Ltd. in connection with US$3.3 billion buyout

August 2015 David Lamb

Conyers Dill & Pearman is providing Cayman law advice to New WuXi Life Science Ltd. in connection with a US$3.3 billion buyout of WuXi PharmaTech Inc., a US listed Chinese company, which is expected to close in Q4 of 2015.

David Lamb of Conyers’ Hong Kong office, is advising on the matter, working alongside Wilson Sonsini Goodrich & Rosati, Sullivan & Cromwell, Weil Gotshal & Manges and Fangda Partners.

 


David Lamb
Partner

Hong Kong   +852 2842 9511

Mobile   +852 6469 3377


Accolades
_

"Few firms can come close to Conyers on one critical metric, and this is the breadth of the client base."
- IFLR1000

expertise

Corporate


Related Jurisdictions

Cayman Islands


Related International Markets

Cayman Islands
Hong Kong


Media Contact

For media enquiries, please contact media@conyersdill.com

Deals & Transactions

Conyers advises New WuXi Life Science Ltd. in connection with US$3.3 billion buyout

14 August 2015 David Lamb

Conyers Dill & Pearman is providing Cayman law advice to New WuXi Life Science Ltd. in connection with a US$3.3 billion buyout of WuXi PharmaTech Inc., a US listed Chinese company, which is expected to close in Q4 of 2015.

David Lamb of Conyers’ Hong Kong office, is advising on the matter, working alongside Wilson Sonsini Goodrich & Rosati, Sullivan & Cromwell, Weil Gotshal & Manges and Fangda Partners.

 


David Lamb
Partner

Hong Kong   +852 2842 9511

Mobile   +852 6469 3377


 

expertise

Corporate


JURISDICTION(S)

Cayman Islands


International Office(s)

Cayman Islands
Hong Kong